Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of a Haplotype in the NR3C2 Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous Chorioretinopathy.
van Dijk EHC, Schellevis RL, van Bergen MGJM, Breukink MB, Altay L, Scholz P, Fauser S, Meijer OC, Hoyng CB, den Hollander AI, Boon CJF, de Jong EK. van Dijk EHC, et al. Among authors: scholz p. JAMA Ophthalmol. 2017 May 1;135(5):446-451. doi: 10.1001/jamaophthalmol.2017.0245. JAMA Ophthalmol. 2017. PMID: 28334414 Free PMC article.
Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.
van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Blanco-Garavito R, Souied EH, Keunen JEE, MacLaren RE, Querques G, Fauser S, Downes SM, Hoyng CB, Boon CJF. van Rijssen TJ, et al. Among authors: scholz p. Am J Ophthalmol. 2019 Sep;205:1-10. doi: 10.1016/j.ajo.2019.03.025. Epub 2019 Apr 3. Am J Ophthalmol. 2019. PMID: 30951686 Clinical Trial.
Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage.
van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Blanco-Garavito R, Souied EH, MacLaren RE, Querques G, Fauser S, Hoyng CB, Downes SM, Boon CJF. van Rijssen TJ, et al. Among authors: scholz p. Graefes Arch Clin Exp Ophthalmol. 2019 Jul;257(7):1419-1425. doi: 10.1007/s00417-019-04333-y. Epub 2019 May 23. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 31123815
Reply to Comment on: Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.
van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Blanco-Garavito R, Souied EH, Keunen JEE, MacLaren RE, Querques G, Fauser S, Downes SM, Hoyng CB, Boon CJF. van Rijssen TJ, et al. Among authors: scholz p. Am J Ophthalmol. 2020 Apr;212:187-188. doi: 10.1016/j.ajo.2019.11.022. Epub 2020 Jan 29. Am J Ophthalmol. 2020. PMID: 32007226 No abstract available.
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial.
van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Dijkman G, Peters PJH, Tsonaka R, MacLaren RE, Downes SM, Fauser S, Boon CJF, Hoyng CB. van Rijssen TJ, et al. Among authors: scholz p. Am J Ophthalmol. 2020 Aug;216:80-89. doi: 10.1016/j.ajo.2020.04.007. Epub 2020 Apr 11. Am J Ophthalmol. 2020. PMID: 32289294 Free article. Clinical Trial.
329 results